Articles - 3nnv mentioned but not cited (4)
- Structural and evolutionary divergence of eukaryotic protein kinases in Apicomplexa. Talevich E, Mirza A, Kannan N. BMC Evol Biol 11 321 (2011)
- p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma. Yang L, Sun X, Ye Y, Lu Y, Zuo J, Liu W, Elcock A, Zhu S. Front Oncol 9 1294 (2019)
- Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology. Da C, Zhang D, Stashko M, Vasileiadi E, Parker RE, Minson KA, Huey MG, Huelse JM, Hunter D, Gilbert TSK, Norris-Drouin J, Miley M, Herring LE, Graves LM, DeRyckere D, Earp HS, Graham DK, Frye SV, Wang X, Kireev D. J Am Chem Soc 141 15700-15709 (2019)
- Rapid Identification of Inhibitors and Prediction of Ligand Selectivity for Multiple Proteins: Application to Protein Kinases. Ma Z, Huang SY, Cheng F, Zou X. J Phys Chem B 125 2288-2298 (2021)
Reviews citing this publication (3)
- Targeted therapy in GIST: in silico modeling for prediction of resistance. Pierotti MA, Tamborini E, Negri T, Pricl S, Pilotti S. Nat Rev Clin Oncol 8 161-170 (2011)
- A Comprehensive Structural Overview of p38α Mitogen-Activated Protein Kinase in Complex with ATP-Site and Non-ATP-Site Binders. Astolfi A, Manfroni G, Cecchetti V, Barreca ML. ChemMedChem 13 7-14 (2018)
- Molecular mechanisms of drug resistance in tyrosine kinases cAbl and cKit. DiNitto JP, Wu JC. Crit Rev Biochem Mol Biol 46 295-309 (2011)
Articles citing this publication (5)
- Natural-product-derived fragments for fragment-based ligand discovery. Over B, Wetzel S, Grütter C, Nakai Y, Renner S, Rauh D, Waldmann H. Nat Chem 5 21-28 (2013)
- Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases. Cowan-Jacob SW, Jahnke W, Knapp S. Future Med Chem 6 541-561 (2014)
- Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by Macrophages. Smith BD, Kaufman MD, Wise SC, Ahn YM, Caldwell TM, Leary CB, Lu WP, Tan G, Vogeti L, Vogeti S, Wilky BA, Davis LE, Sharma M, Ruiz-Soto R, Flynn DL. Mol Cancer Ther 20 2098-2109 (2021)
- Virtual screening using a conformationally flexible target protein: models for ligand binding to p38α MAPK. Vinh NB, Simpson JS, Scammells PJ, Chalmers DK. J Comput Aided Mol Des 26 409-423 (2012)
- Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis. El-Miligy MM, Abd El Razik HA, Abu-Serie MM. Future Med Chem 9 1709-1729 (2017)